{
    "nctId": "NCT03400215",
    "briefTitle": "Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer",
    "officialTitle": "Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 135,
    "primaryOutcomeMeasure": "To compare GSI-measured breast SFA fraction between women with malignant and benign lesions.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* No contraindications to MRI scanning (pacemaker, implanted metallic objects, severe obesity or other condition that leads to difficulty lying in the magnet)\n* No contraindication to gadolinium contrast agent (severe renal insufficiency (EGFR\\<30), allergy to gadolinium) which will be injected for clinical exam\n* Able and willing to provide informed consent\n* Post-menopausal age \\> 25 years.\n\nExclusion Criteria:\n\n* Contra-indication to MRI or gadolinium contrast agent (have a pacemaker, aneurysm clip, or other metallic implant; weigh \\>135 kg; or have renal impairment)\n* Breast surgery within prior 12 months, or breast implants\n* Any hormonal therapy",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}